Ambu A/S
Ambu A/S (AMBFF) Financial Performance & Income Statement Overview
Explore the financials of Ambu A/S (AMBFF), including yearly and quarterly data on income, cash flow, and balance sheets.
Ambu A/S (AMBFF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Ambu A/S AMBFF financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.55B | $1.51B | $1.39B | $1.38B |
| Cost of Revenue | $612.00M | $585.00M | $570.00M | $551.00M |
| Gross Profit | $942.00M | $925.00M | $817.00M | $832.00M |
| Gross Profit Ratio | $0.61 | $0.61 | $0.59 | $0.60 |
| R&D Expenses | $88.00M | $79.00M | $86.00M | $84.00M |
| SG&A Expenses | $630.00M | $603.00M | $584.00M | $570.00M |
| Operating Expenses | $718.00M | $682.00M | $670.00M | $654.00M |
| Total Costs & Expenses | $1.33B | $1.27B | $1.24B | $1.21B |
| Interest Income | $4.00M | $4.00M | $6.00M | $3.00M |
| Interest Expense | $20.00M | $10.00M | $0.00 | $7.00M |
| Depreciation & Amortization | $94.00M | $88.00M | $88.00M | $89.00M |
| EBITDA | $322.00M | $335.00M | $248.00M | $270.00M |
| EBITDA Ratio | $0.21 | $0.22 | $0.18 | $0.20 |
| Operating Income | $224.00M | $243.00M | -$187.00M | $178.00M |
| Operating Income Ratio | $0.14 | $0.16 | -$0.13 | $0.13 |
| Other Income/Expenses (Net) | -$16.00M | -$6.00M | $6.00M | -$4.00M |
| Income Before Tax | $208.00M | $237.00M | -$181.00M | $174.00M |
| Income Before Tax Ratio | $0.13 | $0.16 | -$0.13 | $0.13 |
| Income Tax Expense | $20.00M | $54.00M | -$46.00M | $40.00M |
| Net Income | $188.00M | $183.00M | -$135.00M | $134.00M |
| Net Income Ratio | $0.12 | $0.12 | -$0.10 | $0.10 |
| EPS | $0.71 | $0.68 | -$0.51 | $0.50 |
| Diluted EPS | $0.71 | $0.68 | -$0.51 | $0.50 |
| Weighted Avg Shares Outstanding | $264.79M | $269.12M | $264.71M | $268.00M |
| Weighted Avg Shares Outstanding (Diluted) | $264.79M | $269.12M | $264.71M | $268.00M |
The company's financials show resilient growth, with revenue advancing from $1.38B in Q3 2024 to $1.55B in Q2 2025. Gross profit remained healthy with margins at 61% in Q2 2025 compared to 60% in Q3 2024. Operating income hit $224.00M last quarter, sustaining a consistent 14% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $322.00M. Net income rose to $188.00M, while earnings per share reached $0.71. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan